SCNN1A expression in triple-negative breast cancer: clinical implications for prognosis and neoadjuvant therapy response
SCNN1A overexpression is associated with poor prognosis and non-pCR status in TNBC patients undergoing neoadjuvant chemotherapy.
Authors
- Xin Jin (ORCID: https://orcid.org/0000-0001-7300-828X)
- Yue Ge (ORCID: https://orcid.org/0009-0007-7351-4554)
- Yan Zhao (ORCID: https://orcid.org/0000-0002-7326-8695)
- Ligong Zhang (ORCID: https://orcid.org/0000-0002-9290-8520)
- Tao Sun (ORCID: https://orcid.org/0000-0001-5931-386X)
- Fan Yin (ORCID: https://orcid.org/0000-0001-5460-1117)
- Yunfei Ma
- Jun Qian (ORCID: https://orcid.org/0000-0002-1821-8580)
- Qiang Xie (ORCID: https://orcid.org/0000-0003-1369-6492)
Institutions
- Bengbu Medical College (CN)
- Anhui Medical University (CN)
- First Affiliated Hospital of Bengbu Medical College (CN)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2025-04-26
- DOI
- https://doi.org/10.1186/s12957-025-03698-1
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Anhui Provincial Department of Education
- Wu Jieping Medical Foundation